Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation

AE Tebo - Lupus, 2014 - journals.sagepub.com
The presence of lupus anticoagulant, moderate-to-high levels of IgG and/or IgM antibodies
to beta-2 glycoprotein I or cardiolipin in association with at least one of the two major clinical …

Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation.

AE Tebo - Lupus, 2014 - search.ebscohost.com
The presence of lupus anticoagulant, moderate-to-high levels of IgG and/or IgM antibodies
to beta-2 glycoprotein I or cardiolipin in association with at least one of the two major clinical …

Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation.

AE Tebo - Lupus, 2014 - europepmc.org
The presence of lupus anticoagulant, moderate-to-high levels of IgG and/or IgM antibodies
to beta-2 glycoprotein I or cardiolipin in association with at least one of the two major clinical …

Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation

AE Tebo - Lupus, 2014 - search.proquest.com
The presence of lupus anticoagulant, moderate-to-high levels of IgG and/or IgM antibodies
to beta-2 glycoprotein I or cardiolipin in association with at least one of the two major clinical …

Antiphospholipid syndrome and the relevance of antibodies to negatively charged phospholipids in diagnostic evaluation

AE Tebo - Lupus, 2014 - pubmed.ncbi.nlm.nih.gov
The presence of lupus anticoagulant, moderate-to-high levels of IgG and/or IgM antibodies
to beta-2 glycoprotein I or cardiolipin in association with at least one of the two major clinical …